HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Gilleaudeau Selected Research

OKT4A monoclonal antibody

10/2000Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Gilleaudeau Research Topics

Disease

2Hidradenitis Suppurativa
01/2021 - 01/2019
2Psoriasis (Pustulosis Palmaris et Plantaris)
10/2000 - 09/2000
1Chronic Disease (Chronic Diseases)
10/2000
1Autoimmune Diseases (Autoimmune Disease)
09/2000

Drug/Important Bio-Agent (IBA)

1brodalumabIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Monoclonal AntibodiesIBA
10/2000
1OKT4A monoclonal antibodyIBA
10/2000
1Interleukin-2 (IL2)IBA
09/2000
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2000
1Daclizumab (Zenapax)FDA Link
09/2000